SARS-CoV-2 M ^pro inhibitors with antiviral activity in a transgenic mouse model

Jingxin Qiao, Yueshan Li, Rui Zeng, +40

Science

SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target

Bingqing Xia, Xu-Rui Shen, Yang He, +31

Cell Research

Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models

Gan Wang, Mengli Yang, Zilei Duan, +15

Cell Research

Blood–brain barrier injury and neuroinflammation induced by SARS-CoV-2 in a lung–brain microphysiological system

Peng Wang, Lin Jin, Min Zhang, +11

Nature Biomedical Engineering

InflammationBlood–brain BarrierLung InflammationMedicineDisease Pathophysiology +9

A short peptide from frog skin accelerates diabetic wound healing

Han Liu, Zilei Duan, Jing Tang, +3

FEBS Journal

Transferrin receptor is another receptor for SARS-CoV-2 entry

Xiaopeng Tang, Mengli Yang, Zilei Duan, +13

Virus Spike ProteinMedicineVirus EntryViral PathogenesisImmunology +13

The 14-3-3ζ–c-Src–integrin-β3 complex is vital for platelet activation

Chuanbin Shen, Ming Liu, Runjia Xu, +12

Blood

A Small Peptide with Therapeutic Potential for Inflammatory Acne Vulgaris

Zhiye Zhang, Lixian Mu, Jing Tang, +5

PLoS ONE

Inflammatory Lung DiseasePeptide EngineeringImmunologySmall PeptideInnate Immunity +21

Human transferrin receptor can mediate SARS-CoV-2 infection

Zhiyi Liao, Chaoming Wang, Xiaopeng Tang, +19

Proceedings of the National Academy of Sciences

Rapid generation of ACE2 humanized inbred mouse model for COVID-19 with tetraploid complementation

Feng‐Liang Liu, Kaixin Wu, Jiaoyang Sun, +18

National Science Review

Knockout MouseDisease ModelsInfectious Disease ModellingHace2 MiceTransgenic Mouse Models +13